EP
EDGEWELL PERSONAL CARE Co (EPC)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 was below expectations: organic net sales down 4.2% to $627.2M, GAAP EPS $0.62 and adjusted EPS $0.92; weakness stemmed from very weak Sun Care seasons in North America and certain LatAm markets, plus FX and tariffs headwinds .
- Results missed Wall Street consensus: Revenue $627.2M vs $653.6M*, Adjusted EPS $0.92 vs $0.99*, and Adjusted EBITDA $96.4M vs $102.4M*; management cut FY25 guidance across EPS, EBITDA, margins, and free cash flow, while lowering organic sales to approximately -1.3% .
- International remained resilient with +2.2% organic growth and strengthened market shares; U.S. saw share improvements in Hawaiian Tropic, Hydro Silk, and Cremo supported by stepped-up investments, but elevated A&P and trade spend weighed on profit .
- FY25 outlook: Adjusted EPS now ~$2.65 (from $2.85–$3.05), Adjusted EBITDA ~$312M (from $329–$341M), adjusted operating margin down ~150bps, and FCF ~$80M (from $130–$140M); currency headwind increased, tariffs added costs, and investment levels stay elevated into Q4 .
- Stock reaction catalysts: broad guidance cut, sun-season shortfall, tariff/FX commentary, and visible U.S. brand-share gains that may support medium-term re-rating as 2026 plans firm up .
What Went Well and What Went Wrong
What Went Well
- International performance: another quarter of growth and strengthened share; management highlighted 2.2% organic growth internationally, mid- to high-single-digit multi-year trajectory, and strong execution in Greater China, Oceania, and Europe .
- Brand activation success: “Tana Sutra” campaign for Hawaiian Tropic drove 18% dollar consumption growth and +150bps share in a declining U.S. sun category; Cremo posted ~35% consumption growth, and Hydro Silk share improved sequentially with modernized activation .
- Productivity and supply chain: realized ~270bps gross savings; strong unit fill and OTIF rates supported mitigation of tariff/FX pressures and elevated brand investments .
What Went Wrong
- Sun Care seasonality and weather: materially weak U.S. and Mexico/Puerto Rico sun consumption during Memorial Day–July 4 window created ~$25M underperformance in Q3, lowering mix and increasing trade spend .
- Tariffs and currency: FY25 currency headwind increased to ~$29M on EBITDA and ~$0.46/share on EPS; tariffs expected to be ~$5M P&L hit in FY25 (cash ~$10M), with gross tariffs potentially $40–$50M annualized absent mitigation .
- Feminine Care and North America softness: North America organic sales declined ~8% with retailer destocking (especially tampons); Feminine Care net sales down 10.5% and segment profit down 31.8% y/y .
Financial Results
Consolidated Quarterly Performance vs Prior Periods
Q3 2025 Actual vs Consensus
Values with * retrieved from S&P Global.
Year-over-Year Q3 Comparison
Segment Breakdown (Q3 2025 vs Q3 2024)
KPIs and Cash/Capital
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “This was a challenging quarter… significantly impacted by very weak Sun Care seasons in North America and certain Latin American markets… tariffs and foreign exchange contributing to full-year profit headwinds.” — Rod Little, CEO .
- “We saw improved market share performance from… Hawaiian Tropic, Cremo, and Hydro Silk… investments weigh on profitability in the near term, [but] better position our portfolio for a stronger 2026 and beyond.” — Rod Little, CEO .
- “Operationally, productivity savings remain an important lever in gross margin performance, delivering 270 basis points of tailwinds in the quarter.” — Dan Sullivan, COO .
- “We are orchestrating significant change across our North America commercial operations… we will continue to press forward on investment… setting us up for long term success.” — Rod Little, CEO .
Q&A Highlights
- Free cash flow and leverage: Management attributed FCF cut ~2/3 to lower earnings/FX/tariffs and ~1/3 to working capital (higher sun inventory, tariff pre-buys, Mexican consolidation); reiterated structural ability to generate strong cash flow over time .
- Q4 organic growth drivers: International step-up via pricing, NPD (incl. Billie), and private brand tenders; North America improvement from Sun Care rebound (~4%), Fem Care low-single-digit growth, and Wet Ones cycling fire-related impacts .
- Sun Care inventory/replenishment: Expecting flat-to-slightly-down season overall, with mid-single-digit upturn in final stretch; supply chain proximity aids faster replenishment; Banana Boat more weather-sensitive vs Hawaiian Tropic’s branding momentum .
- Wet Shave dynamics and Billie body: U.S. women’s razor space remains highly promotional; Hydro Silk sequentially improved; Billie’s body range under review after mixed retailer thresholds, but Billie’s core shave share now ~11% nationally with gains at Walmart/Target .
Estimates Context
- Q3 2025 compared to consensus: Revenue $627.2M vs $653.6M*, Adjusted EPS $0.92 vs $0.99*, Adjusted EBITDA $96.4M vs $102.4M* — broad misses driven by Sun Care weakness, higher trade spend, FX/tariff headwinds, and elevated A&P .
- Consensus backdrop: Target Price Consensus Mean ~$23.86*; recommendation text unavailable via S&P Global in this pull. Values retrieved from S&P Global.
Key Takeaways for Investors
- Near-term pressure persists: broad Q3 misses vs consensus and a material FY25 guidance cut across EPS/EBITDA/margins/FCF underscore transitory but significant Sun Care/FX/tariff headwinds and elevated U.S. investment .
- Resilience internationally and share gains domestically: International growth and share strength continue; U.S. brand-share trends (Hawaiian Tropic, Hydro Silk, Cremo) improving, suggesting investments are working despite near-term margin dilution .
- Tariff/FX risks raised: Currency headwind lifted to
$29M EBITDA/$0.46 EPS and tariffs could be $40–$50M annualized gross absent mitigation; expect continued supply chain actions and pricing to offset over time . - Q4 setup improving: Management tracking to ~2.5% organic growth on a constant currency basis with flat adjusted GM and ~2% adjusted EBITDA growth despite higher brand spend and tariff headwinds; July performance on track .
- Cash discipline vs investment: FCF lowered to
$80M due to earnings/working capital/tariffs; repurchases ($90M FY25) maintained, dividend steady; watch leverage trajectory and H2 cash conversion . - 2026 focus: Management confidence in returning to 2–3% growth algorithm post U.S. transformation; monitor November update for specifics and tariff policy clarity .
- Trading lens: Narrative likely driven by weather-normalized Sun Care recovery into Q4, evidence of U.S. share sustainment with stepped-up A&P, and any relief or clarity on tariffs/FX; medium-term re-rating hinges on U.S. margin recapture and cash flow normalization .